Exclusive

Publication

Byline

Singapore Clinical Trial: A Phase 2/3 Randomized Study to Evaluate the Safety, Efficacy, and Optimal Dose of Telisotuzumab Adizutecan in Combination with Osimertinib as First-Line Treatment in Patients with Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

Singapore, April 10 -- The Health Sciences Authority received information related to the study titled 'A Phase 2/3 Randomized Study to Evaluate the Safety, Efficacy, and Optimal Dose of Telisotuzumab ... Read More


Singapore Clinical Trial: A Study to Evaluate the Effect of Fasting Duration and Temporary Withholding of Tirzepatide on Retained Gastric Contents Using Gastric Ultrasound in Participants with Type 2 Diabetes Mellitus and Participants with Overweight or Obesity without Type 2 Diabetes Mellitus.

Singapore, April 10 -- The Health Sciences Authority received information related to the study titled 'A Study to Evaluate the Effect of Fasting Duration and Temporary Withholding of Tirzepatide on Re... Read More


Singapore Clinical Trial: A Phase 1/2 Open-Label, Umbrella Platform Design Study of Investigational Agents in Combination With Pembrolizumab (MK-3475) With or Without Chemotherapy in Participants With 1L Locally Advanced Unresectable/Metastatic Esophageal Cancer: KEYMAKER-U06 Substudy 06E

Singapore, April 10 -- The Health Sciences Authority received information related to the study titled 'A Phase 1/2 Open-Label, Umbrella Platform Design Study of Investigational Agents in Combination W... Read More


Singapore Clinical Trial: EASi-PROTKT™ - A Phase III double-blind, randomised, parallel-group superiority trial to evaluate efficacy and safety of the combined use of oral vicadrostat (BI 690517) and empagliflozin compared with placebo and empagliflozin in participants with type 2 diabetes, hypertension and established cardiovascular disease

Singapore, April 10 -- The Health Sciences Authority received information related to the study titled 'EASi-PROTKT™ - A Phase III double-blind, randomised, parallel-group superiority trial to evaluate... Read More


Clinical Trial: Clinical Study on the Safety and Immunogenicity of Specific Cancer Vaccines in Preventing Recurrence of Glioblastoma

U.S., April 10 -- ClinicalTrials.gov registry received information related to the study (NCT07520214) titled 'Clinical Study on the Safety and Immunogenicity of Specific Cancer Vaccines in Preventing ... Read More


Clinical Trial: Effectiveness of Extra-corporeal Shockwave Diathermy in the Management of Upper Limb Function Patients With Stroke.

U.S., April 10 -- ClinicalTrials.gov registry received information related to the study (NCT07520032) titled 'Effectiveness of Extra-corporeal Shockwave Diathermy in the Management of Upper Limb Funct... Read More


Clinical Trial: CAR 70-BCMA CAR-T Cells for the Treatment of Relapsed or Refractory Plasma Cell Neoplasms

U.S., April 10 -- ClinicalTrials.gov registry received information related to the study (NCT07519187) titled 'CAR 70-BCMA CAR-T Cells for the Treatment of Relapsed or Refractory Plasma Cell Neoplasms'... Read More


Clinical Trial: The Role of Bioelements in Fibromyalgia: Disease Activity or Depression-Anxiety?

U.S., April 10 -- ClinicalTrials.gov registry received information related to the study (NCT07519824) titled 'The Role of Bioelements in Fibromyalgia: Disease Activity or Depression-Anxiety?' on March... Read More


Clinical Trial: TECAR and ESWT in Obesity-Related Lower Limb Lymphedema

U.S., April 10 -- ClinicalTrials.gov registry received information related to the study (NCT07520942) titled 'TECAR and ESWT in Obesity-Related Lower Limb Lymphedema' on April 03. Brief Summary: This... Read More


Orban's rural base is still behind the Hungarian leader ahead of Sunday's pivotal vote

New Delhi, April 10 -- Istvan Varoczi, a 63-year-old entrepreneur from the small Hungarian city of Cegled, says he doesn't believe the polls that show Prime Minister Viktor Orban could lose a pivotal ... Read More